Recently, we described the discovery of a novel gold nano-particle (AuNP) catalyzed reaction, which allows one to make heavily cross-linked polymer shells on the surface of the NP. [1] With this reaction, the NP acts both as a scaffold and catalyst to facilitate the crosslinking of linear polymers with propargyl ether side chains. Specifically, it has been postulated that hydroxy groups, formed from the hydrolysis of the propargyl ethers, add to the alkynes adsorbed on the gold surface, leading to cross-linking of the polymer. [2] Importantly, the NP core can be subsequently removed to form hollow polymer nanopods. These structures, which are highly adaptable through choice of polymer and AuNP template, show promise for many applications, spanning molecular diagnostics, [3] drug delivery, [4] materials synthesis, and colloidal crystal design. [5] However, before they can be fully utilized, methods for functionalizing them with bioactive structures must be developed. In this regard, we have devised methods for making nanopods from oligonucleotides with modified bases to generate polyvalent oligonucleotide nanostructures, which now constitute an entire class of single-entity intracellular gene regulation agents. [6] Herein, we address the challenge of creating nanopods functionalized with antibodies (Abs) by creating a class of materials, termed immunopods (IPs), structures that can be made from Abs and the appropriate linear polymers with propragyl ether side chains in a one-pot fashion, and then explore their ability to selectively target cells. IPs are important entries in the class of structures that can be made by gold-particle surface-templated and catalyzed approaches since they can enable a wide variety of pharmaceutical studies and potential applications.Given the broad utility of Ab-NP conjugates, many strategies to attach an Ab to surfaces have been developed. These strategies largely fall into two categories: specific and nonspecific. [7] In nonspecific attachment methods, van der Waals or electrostatic interactions are typically utilized. However, successful in vivo application often requires structures that do not nonspecifically bind to cells, making surfaces composed of [**] C.A.M. acknowledges the